These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9507498)

  • 1. Lipid abnormalities in end stage renal disease.
    Oda H; Keane WF
    Nephrol Dial Transplant; 1998; 13 Suppl 1():45-9. PubMed ID: 9507498
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of peritoneal dialysis solution type on serum lipid levels in end-stage renal disease.
    Kanbay M; Bavbek N; Delibasi T; Koca C; Kaya A; Altay M; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2007; 29(3):309-13. PubMed ID: 17497445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol and lipid disturbances in renal disease: the natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis.
    Avram MM; Fein PA; Antignani A; Mittman N; Mushnick RA; Lustig AR; Lapuz MH; Goldwasser P
    Am J Med; 1989 Nov; 87(5N):55N-60N. PubMed ID: 2486549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T; Miyamae M; Tomonaga O; Omori Y
    Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peritoneal dialysis in the treatment of chronic renal failure].
    Kazimirov VG; Butrin SV; Bekov RR; Sapozhnikov AD; Kharitonov BI; Smoliakov AM; Detinenko IN
    Urologiia; 2004; (5):58-62. PubMed ID: 15560166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. III. Treatment modalities for ESRD patients.
    Am J Kidney Dis; 1999 Aug; 34(2 Suppl 1):S51-62. PubMed ID: 10431002
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kidneys and lipids].
    Bagros P; Aparicio M
    Rev Prat; 1992 Feb; 42(4):417-20. PubMed ID: 1604159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease.
    N Engl J Med; 1982 Oct; 307(17):1082-4. PubMed ID: 6750398
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival with end-stage renal disease.
    Anderson RJ
    Med Sect Proc; 1983; ():115-8. PubMed ID: 6379639
    [No Abstract]   [Full Text] [Related]  

  • 10. [Substitute treatment of end-stage renal insufficiency in Tunisia].
    el Matri A; Ben Abdallah T; Kechrid C; Ben Maiz H; Kheder A; Ben Ayed H
    Tunis Med; 1986 May; 64(5):445-9. PubMed ID: 3547964
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in left ventricular anatomy during haemodialysis, continuous ambulatory peritoneal dialysis and after renal transplantation.
    Deligiannis A; Paschalidou E; Sakellariou G; Vargemezis V; Geleris P; Kontopoulos A; Papadimitriou M
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():185-9. PubMed ID: 3157986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dialysis as bridge therapy for renal transplantation: single center experience, a comparison of hemodialysis and continuous ambulatory peritoneal dialysis].
    Mitome J; Yamamoto H; Kato N; Hayakawa H; Ikeda M; Yokoyama K; Nakayama M; Kawaguchi Y; Hosoya T
    Nihon Jinzo Gakkai Shi; 2005; 47(7):813-20. PubMed ID: 16296411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
    Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abnormalities of lipid metabolism in chronic dialysis patients].
    Fujioka T; Saito E; Yasugi T; Shimizu T
    Nihon Rinsho; 1992 Jan; 50 Suppl():527-34. PubMed ID: 1578734
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of end-stage renal failure in Hong Kong.
    Chan MK
    Contrib Nephrol; 1990; 82():25-30. PubMed ID: 2093523
    [No Abstract]   [Full Text] [Related]  

  • 16. Low serum CA125 concentration in chronic renal failure treated with continuous ambulatory peritoneal dialysis.
    Kawabe T; Ishii M; Sugimoto T; Tagawa H
    Clin Chim Acta; 1987 Sep; 168(1):113-4. PubMed ID: 3478159
    [No Abstract]   [Full Text] [Related]  

  • 17. [Total serum lipids in chronic renal failure treated by repeated hemodialysis and kidney transplantation].
    Juskowa J; Barańska E
    Pol Arch Med Wewn; 1981 Jul; 66(1):33-41. PubMed ID: 7027199
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost analysis of alternative treatments in end-stage renal disease.
    Karlberg I
    Transplant Proc; 1992 Feb; 24(1):335. PubMed ID: 1539301
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism and kinetics of propylurofuranic acid in end-stage renal failure.
    Shinzato T; Morita H; Maeda K
    ASAIO J; 1994; 40(1):94-6. PubMed ID: 8186503
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum lipids in black Africans on chronic ambulatory peritoneal dialysis.
    Abiola OO; Olubodun JO; Agbedana EO; Taylor GO
    Perit Dial Int; 1996; 16(3):333-4. PubMed ID: 8761558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.